You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

paclitaxel

Showing 1 - 25 of 1,519
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial (albumin-bound paclitaxel, paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • albumin-bound paclitaxel
  • paclitaxel
  • (no location specified)
Mar 31, 2022

NSCLC Trial in Shanghai (Pembrolizumab, Paclitaxel, Nab-paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +4 more
  • Shanghai, China
    Zhongshan Hospital Fudan University
Aug 18, 2022

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

NSCLC Trial (Pembrolizumab, Paclitaxel, Nab-paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +4 more
  • (no location specified)
Jan 20, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Ovarian Cancer, Relapsed or Refractory, Chiauranib Trial in Shanghai (chiauranib, Placebo, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 7, 2022

NSCLC Trial in United States (Napabucasin, Paclitaxel)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +4 more
Apr 4, 2022

Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the

Active, not recruiting
Has Results
  • Human Papilloma Virus Infection
  • +3 more
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +8 more
  • Chicago, Illinois
    University of Chicago
Mar 2, 2022

STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER Trial in United States (NAB-PACLITAXEL, PACLITAXEL)

Completed
Has Results
  • STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
  • Rochester, New York
  • +4 more
Oct 5, 2021

Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Breast - Female
  • Male Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Jul 11, 2022

Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

Not yet recruiting
  • Small-cell Lung Cancer
  • Neuroendocrine Carcinoma
  • (no location specified)
Jun 13, 2022

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • Pegylated liposomal doxorubicin
  • Paclitaxel
  • (no location specified)
Jul 20, 2022

Triple-Negative Breast Cancer Trial in Taiwan (EndoTAG-1, Paclitaxel, Gemcitabine Hydrochloride)

Recruiting
  • Triple-Negative Breast Cancer
  • Kaohsiung, Taiwan
  • +5 more
Feb 18, 2022

Breast Cancer Female, Peripheral Neuropathy Trial in Cairo (Pentoxifylline, Paclitaxel, Placebo)

Recruiting
  • Breast Cancer Female
  • Peripheral Neuropathy
  • Cairo, Abbasia, Egypt
    Ain Shams University hospitals
Jan 8, 2022

Peritoneal Carcinomatosis Trial in Singapore (Paclitaxel)

Not yet recruiting
  • Peritoneal Carcinomatosis
  • Paclitaxel
  • Singapore, Singapore
    National University Hospital
May 24, 2022

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Aug 17, 2022

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
May 16, 2022

Advanced Solid Tumours Trial in Shanghai (Capivasertib, Paclitaxel)

Completed
  • Advanced Solid Tumours
  • Shanghai, China
    Research Site
Aug 18, 2022

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Apr 1, 2022

Solid Tumor, Adult Trial in Shanghai (EOC202, Paclitaxel)

Completed
  • Solid Tumor, Adult
  • EOC202
  • Paclitaxel
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 30, 2022

Peritoneal Carcinomatosis, Peritoneal Tumors, Ovarian Cancer Trial run by the National Cancer Institute (NCI) (Paclitaxel,

Not yet recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Gastric Cancer, Chemo Effect, Surgery Trial in Wuhan (Paclitaxel, Lobaplatin)

Recruiting
  • Gastric Cancer
  • +4 more
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Feb 18, 2022

Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

Terminated
  • Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Mar 23, 2022